38.595 USD
-0.84 (-2.14%)
Taking everything into account, PDEX scores 5 out of 10 in our fundamental rating. PDEX was compared to 186 industry peers in the Health Care Equipment & Supplies industry. PDEX has an excellent profitability rating, but there are some minor concerns on its financial health. PDEX has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year PDEX was profitable.
In the past year PDEX has reported a negative cash flow from operations.
Each year in the past 5 years PDEX has been profitable.
The reported operating cash flow has been mixed in the past 5 years: PDEX reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of PDEX (17.41%) is better than 98.39% of its industry peers.
PDEX has a Return On Equity of 26.96%. This is amongst the best in the industry. PDEX outperforms 97.85% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.51%, PDEX belongs to the top of the industry, outperforming 96.24% of the companies in the same industry.
PDEX had an Average Return On Invested Capital over the past 3 years of 14.16%. This is significantly above the industry average of 8.84%.
The 3 year average ROIC (14.16%) for PDEX is below the current ROIC(16.51%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROIC | 16.51% |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
1.3 Margins
The Profit Margin of PDEX (15.94%) is better than 91.94% of its industry peers.
In the last couple of years the Profit Margin of PDEX has declined.
PDEX's Operating Margin of 15.36% is amongst the best of the industry. PDEX outperforms 83.87% of its industry peers.
PDEX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 28.09%, PDEX is doing worse than 77.42% of the companies in the same industry.
In the last couple of years the Gross Margin of PDEX has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% |
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PDEX is creating value.
Compared to 1 year ago, PDEX has less shares outstanding
Compared to 5 years ago, PDEX has less shares outstanding
Compared to 1 year ago, PDEX has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 6.54 indicates that PDEX is not in any danger for bankruptcy at the moment.
PDEX has a Altman-Z score of 6.54. This is amongst the best in the industry. PDEX outperforms 82.26% of its industry peers.
A Debt/Equity ratio of 0.21 indicates that PDEX is not too dependend on debt financing.
The Debt to Equity ratio of PDEX (0.21) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 6.54 |
ROIC/WACC1.97
WACC8.36%
2.3 Liquidity
A Current Ratio of 3.73 indicates that PDEX has no problem at all paying its short term obligations.
With a decent Current ratio value of 3.73, PDEX is doing good in the industry, outperforming 65.05% of the companies in the same industry.
A Quick Ratio of 2.14 indicates that PDEX has no problem at all paying its short term obligations.
PDEX's Quick ratio of 2.14 is in line compared to the rest of the industry. PDEX outperforms 57.53% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 |
3. Growth
3.1 Past
PDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.14%, which is quite impressive.
Measured over the past years, PDEX shows a quite strong growth in Earnings Per Share. The EPS has been growing by 10.96% on average per year.
The Revenue has grown by 23.65% in the past year. This is a very strong growth!
Measured over the past years, PDEX shows a quite strong growth in Revenue. The Revenue has been growing by 13.84% on average per year.
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.10, PDEX is valued correctly.
Based on the Price/Earnings ratio, PDEX is valued cheaper than 91.94% of the companies in the same industry.
PDEX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.77.
PDEX is valuated correctly with a Price/Forward Earnings ratio of 15.90.
Compared to the rest of the industry, the Price/Forward Earnings ratio of PDEX indicates a rather cheap valuation: PDEX is cheaper than 85.48% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.35. PDEX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.1 | ||
| Fwd PE | 15.9 |
4.2 Price Multiples
90.86% of the companies in the same industry are more expensive than PDEX, based on the Enterprise Value to EBITDA ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 9.84 |
4.3 Compensation for Growth
PDEX has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.1
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
PDEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PDEX (12/30/2025, 8:00:01 PM)
38.595
-0.84 (-2.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners31.87%
Inst Owner Change-3.05%
Ins Owners36.03%
Ins Owner Change1.64%
Market Cap125.82M
Revenue(TTM)70.23M
Net Income(TTM)11.19M
Analysts82.86
Price Target57.12 (48%)
Short Float %10.16%
Short Ratio4.96
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)74.8%
Min EPS beat(2)-24.91%
Max EPS beat(2)174.51%
EPS beat(4)3
Avg EPS beat(4)69.51%
Min EPS beat(4)-24.91%
Max EPS beat(4)174.51%
EPS beat(8)5
Avg EPS beat(8)44.11%
EPS beat(12)7
Avg EPS beat(12)20.2%
EPS beat(16)8
Avg EPS beat(16)16.17%
Revenue beat(2)1
Avg Revenue beat(2)7.28%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)18.74%
Revenue beat(4)2
Avg Revenue beat(4)7.58%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)19.3%
Revenue beat(8)6
Avg Revenue beat(8)12.93%
Revenue beat(12)9
Avg Revenue beat(12)11.32%
Revenue beat(16)12
Avg Revenue beat(16)11.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.1 | ||
| Fwd PE | 15.9 | ||
| P/S | 1.79 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 3.03 | ||
| P/tB | 3.03 | ||
| EV/EBITDA | 9.84 |
EPS(TTM)3.19
EY8.27%
EPS(NY)2.43
Fwd EY6.29%
FCF(TTM)-0.67
FCFYN/A
OCF(TTM)-0.39
OCFYN/A
SpS21.54
BVpS12.73
TBVpS12.73
PEG (NY)N/A
PEG (5Y)1.1
Graham Number30.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.41% | ||
| ROE | 26.96% | ||
| ROCE | 21.27% | ||
| ROIC | 16.51% | ||
| ROICexc | 20.85% | ||
| ROICexgc | 20.86% | ||
| OM | 15.36% | ||
| PM (TTM) | 15.94% | ||
| GM | 28.09% | ||
| FCFM | N/A |
ROA(3y)10.79%
ROA(5y)11.4%
ROE(3y)17.93%
ROE(5y)20.5%
ROIC(3y)14.16%
ROIC(5y)12.68%
ROICexc(3y)16.6%
ROICexc(5y)14.6%
ROICexgc(3y)16.62%
ROICexgc(5y)14.63%
ROCE(3y)18.25%
ROCE(5y)16.34%
ROICexgc growth 3Y23.73%
ROICexgc growth 5Y-8.41%
ROICexc growth 3Y23.84%
ROICexc growth 5Y-8.25%
OM growth 3Y9.36%
OM growth 5Y-4.56%
PM growth 3Y7.44%
PM growth 5Y-5.13%
GM growth 3Y-2.11%
GM growth 5Y-4.93%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.21 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.72 | ||
| Cap/Depr | 73.12% | ||
| Cap/Sales | 1.3% | ||
| Interest Coverage | 12.57 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.73 | ||
| Quick Ratio | 2.14 | ||
| Altman-Z | 6.54 |
F-Score6
WACC8.36%
ROIC/WACC1.97
Cap/Depr(3y)99.37%
Cap/Depr(5y)344.26%
Cap/Sales(3y)1.93%
Cap/Sales(5y)6.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.14%
EPS 3Y35.1%
EPS 5Y10.96%
EPS Q2Q%86.67%
EPS Next Y-4.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)23.65%
Revenue growth 3Y16.57%
Revenue growth 5Y13.84%
Sales Q2Q%24.43%
Revenue Next Year4.48%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.16%
EBIT growth 3Y27.48%
EBIT growth 5Y8.65%
EBIT Next Year10.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-206.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-142.63%
OCF growth 3YN/A
OCF growth 5YN/A
PRO-DEX INC / PDEX FAQ
Can you provide the ChartMill fundamental rating for PRO-DEX INC?
ChartMill assigns a fundamental rating of 5 / 10 to PDEX.
Can you provide the valuation status for PRO-DEX INC?
ChartMill assigns a valuation rating of 5 / 10 to PRO-DEX INC (PDEX). This can be considered as Fairly Valued.
Can you provide the profitability details for PRO-DEX INC?
PRO-DEX INC (PDEX) has a profitability rating of 7 / 10.
Can you provide the expected EPS growth for PDEX stock?
The Earnings per Share (EPS) of PRO-DEX INC (PDEX) is expected to decline by -4.43% in the next year.